Cupid deposits Rs. 82.88 crore for strategic stake in Baazar Style Retail

The deal gives Cupid immediate access to Style Baazar’s fast-growing network of over 260 stores

Nuvation Bio secures global rights to promising brain tumor drug Safusidenib, expands Phase 3 study to Japan

BASF Pharma Solutions announces up to 20% price hike on excipients and APIs

The company said the increase—up to 20%—takes effect immediately, or as current contracts allow

Concord Biotech acquires Celliimune to accelerate DNA-engineered cancer therapies

Rs 66 lakh acquisition will support DNA engineering and novel cell-gene therapy alternatives to conventional chemotherapy

Jan Vishwas Bill 2026 decriminalises minor health sector offences, eases compliance burden

Parliament clears reform bill replacing jail terms for procedural lapses with graded monetary penalties across key health laws

Sahyadri Hospital brings first non-surgical treatment for severe knee pain to Maharashtra

Low-dose radiotherapy offers immediate pain relief, quicker recovery, and better movement through a non-invasive procedure

ZEISS India strengthens portfolio with the launch of ZEISS ClearMind lenses

Developed for today’s fast-paced, visually demanding lifestyles, the lenses are built on ZEISS NeurOptix technology

Merck secures landmark EU nod for KEYTRUDA in hard-to-treat ovarian cancer

Its a major breakthrough for women’s ovarian cancer care in Europe

Saharsh Davuluri takes over as CEO & MD of Neuland Laboratories

18-year veteran Saharsh will position the CDMO as a premier global API process development and commercial manufacturing specialist

FDA okays Eli Lilly’s new weight-loss pill, expanding options for millions

The approval is backed by results from Lilly’s ATTAIN clinical trial program, which showed significant weight loss among participants